General and administrative expenses were $4.7 million for the quarter ended September ... BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic ...
Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent ...